United States· US:23155-288_d5f7fb75-ef4b-4d7b-a9d6-c4ff08920973

acetazolamide

A acetazolamide product containing acetazolamide, registered in United States by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. The same ATC class is registered in 17 of our 19 countries.

ATC S01EC01US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedacetazolamideATCS01EC01REGISTER NO.US:23155-288_d5f7fb75…PACKS LISTED4CHECKEDSeptember 27, 2026

Where it is registered

Acetazolamide is registered in 17 of 19 countries.

Countries holding a registration under ATC S01EC01 (acetazolamide), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 10 of them publish a price we can compare per daily dose

Acetazolamide · ATC S01EC01

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of acetazolamide costs, country by country.

Normalised to the WHO defined daily dose (0.75 g), the median price runs from $0.40 in United States to $11.42 in France — a ×28 gap.

  • United States: $0.40 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Acetazolamide · price per daily dose (0.75 g)

USD · FX 28 Sept 2026

  • FR France$11.42
  • CH Switzerland$1.93
  • IT Italy$1.30
  • US United States$0.40 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
ACETAZOLAMIDE
Manufacturer
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Country
United States (US)
ATC code
S01EC01
ATC class
Acetazolamide
Defined daily dose
0.75 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 4

  • ndc11
    2315528801
    100 TABLET in 1 BOTTLE (23155-288-01)
  • ndc11
    2315528810
    1000 TABLET in 1 BOTTLE (23155-288-10)
  • ndc11
    23155-288-01
  • ndc11
    23155-288-10

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

203 interactions on record for acetazolamide.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Acetazolamide · interactions on record

203 records

  • 8 severe
  • 130 moderate
  • 7 minor
  • 58 info

Most severe, free to view

  • CisaprideA03FA02severe
  • MetforminA10BA02severe
  • Acetylsalicylic acidB01AC06severe
  • Salicylic acidD01AE12severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Acetazolamide in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All acetazolamide products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Acetazolamid Agepha, Diamox
  • Belgium · Diamox, Diamox Parenteraal
  • Cyprus · Acetazolamide Remedica
  • Czechia · Diluran
  • Germany · Acemit, Acetazolamid Aspire Pharma
  • Denmark · Diamox
  • Spain · Acetazolamida Aspire, Edemox
  • France · Diamox
  • United Kingdom (Northern Ireland) · Acetazolamide, Acetazolamide Blumont Pharma
  • Greece · Acetazolamide Ι.Φ.Ε.Τ.
  • Croatia · Diamox
  • Hungary · Huma-Zolamide
  • Ireland · Diamox, Diamox Sr
  • Iceland · Diamox
  • Italy · Diamox
  • Lithuania · Diacarb
  • Luxembourg · Diamox, Diamox Parenteraal
  • Latvia · Diacarb
  • Malta · Acetazolamide, Acetazolamide Mercury Pharmaceuticals
  • Netherlands · Diamox, Diamox Parenteraal
  • Norway · Diamox
  • Poland · Diuramid
  • Portugal · Carbinib
  • Romania · Acetazolamida Arena
  • Sweden · Diamox
  • Slovakia · Diluran

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b011e956-8504-4cba-b75f-1d25f9e866e7
GET /v1/drugs/b011e956-8504-4cba-b75f-1d25f9e866e7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "250",
  "substance": "ACETAZOLAMIDE",
  "productndc": "23155-288",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA205530",
  "marketing_category": "ANDA"
}

See everything about acetazolamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.